GHRELIN BINDENDE NUKLEINSÄUREN

European patent · EP1530635 · Deleted

Register entry

Publication number
EP1530635
Application number
EP03766390
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 1, 2003
Published
May 18, 2005
Granted
Jun 15, 2011
Deleted
Aug 31, 2013
Reason
Annual fee unpaid
IPC classes
C12N 15/11 (2006.01)
Priority
EP 02017317 01.08.2002
EP 02023637 19.10.2002
EP 03014111 23.06.2003
PCT application
PCT/EP2003/008542 01.08.2003
PCT publication
WO2004/013274 12.02.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 19, 2014

    Deleted, fee unpaid

    Published in Swissreg on 19.03.2014

  2. Aug 16, 2011

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 16.08.2011

  3. Jun 15, 2011

    Granted

    Published in Swissreg on 15.06.2011

Parties

Holder

Noxxon Pharma AG

Max-Dohrn-Strasse 8-10, 10589 Berlin, DE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

HELMLING, Steffen

Narberth, PA 19072, US

EULBERG, Dirk

10247 Berlin, DE

MAASCH, Christian

13509 Berlin, DE

KLUSSMANN, Sven

10709 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.